These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9932721)

  • 1. Effects of Ca2+ channel blockers on apomorphine, bromocriptine and morphine-induced locomotor activity in mice.
    Doğrul A; Yeşilyurt O
    Eur J Pharmacol; 1999 Jan; 364(2-3):175-82. PubMed ID: 9932721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D-1 receptors.
    Jackson DM; Hashizume M
    J Neural Transm; 1987; 69(1-2):131-45. PubMed ID: 2953861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    Zarrindast MR; Poursoltan M
    Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393.
    Jackson DM; Hashizume M
    Psychopharmacology (Berl); 1986; 90(1):147-9. PubMed ID: 3094056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of dopamine receptor agents on naloxone-induced jumping behaviour in morphine-dependent mice.
    Zarrindast MR; Habibi M; Borzabadi S; Fazli-Tabaei S; Hossein Yahyavi S; Rostamin P
    Eur J Pharmacol; 2002 Sep; 451(3):287-93. PubMed ID: 12242090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential involvement of voltage-dependent calcium channels in apomorphine-induced hypermotility and stereotypy.
    Antkiewicz-Michaluk L; Michaluk J; Romańska I; Vetulani J
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):555-60. PubMed ID: 7862875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice.
    Jackson DM; Ross SB; Hashizume M
    Psychopharmacology (Berl); 1988; 94(3):321-7. PubMed ID: 2895938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-type Ca(2+) channel blockers inhibit the development but not the expression of sensitization to morphine in mice.
    Zhang Q; Li JX; Zheng JW; Liu RK; Liang JH
    Eur J Pharmacol; 2003 Apr; 467(1-3):145-50. PubMed ID: 12706468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal variation in the interaction between calcium channel blockers and morphine-induced analgesia.
    Hodoğluğil U; Güney HZ; Savran B; Güzey C; Görgün CZ; Zengil H
    Chronobiol Int; 1996 Aug; 13(3):227-34. PubMed ID: 8874985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diltiazem suppresses apomorphine-induced fighting and pro-aggressive effect of withdrawal from chronic ethanol or haloperidol in rats.
    Pucilowski O; Kostowski W
    Neurosci Lett; 1988 Oct; 93(1):96-100. PubMed ID: 3211374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of microgram doses of haloperidol on open-field behavior in mice.
    Conceição IM; Frussa-Filho R
    Pharmacol Biochem Behav; 1996 Apr; 53(4):833-8. PubMed ID: 8801585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of L-type calcium channels in ethanol-induced behavioral stimulation and motor incoordination: effects of diltiazem and verapamil.
    Baliño P; Pastor R; Aragon CM
    Behav Brain Res; 2010 Jun; 209(2):196-204. PubMed ID: 20122967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice.
    Jenkins OF; Jackson DM
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):7-11. PubMed ID: 3877878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine.
    Barrios M; Baeyens JM
    Psychopharmacology (Berl); 1991; 104(3):397-403. PubMed ID: 1718013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiparkinsonian potential of interaction of LEK-8829 with bromocriptine.
    Zivin M; Sprah L; Sket D
    Eur J Pharmacol; 1998 May; 349(2-3):151-7. PubMed ID: 9671092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing influences of D-1 and D-2 dopamine receptors activation on morphine-induced antinociception.
    Zarrindast MR; Moghaddampour E
    Arch Int Pharmacodyn Ther; 1989; 300():37-50. PubMed ID: 2619426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D(2) receptor activation is critical but not the expression of the unconditioned response.
    Dias FR; Carey RJ; Carrera MP
    Brain Res; 2006 Apr; 1083(1):85-95. PubMed ID: 16530737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.